• Pharma
  • March 8, 2018
  • 180 views
Price crash ahead Key diabetes cancer drugs to go off patent in India

The next three to five years would see some key cardiovascular, diabetic and oncology molecules going off-patent in the Indian market. This could trigger launches of generic versions by local…

  • Pharma
  • March 8, 2018
  • 145 views
Torrent Pharma readies €2 billion binding offer for Sanofi’s European unit

Torrent Pharmaceuticals Ltd is readying a €2 billion (Rs16,000 crore) bid for Zentiva N.V., the generic drugs unit of France’s Sanofi, two people directly aware of the bidding process said.…

  • Pharma
  • March 7, 2018
  • 178 views
Sun Pharma’s travails with US regulator may drag on

MUMBAI : Sun Pharmaceutical’s troubles with the US drug regulator will continue, as details of the recent observations revealed that the resolution of issues at its Halol manufacturing plant might…

  • Pharma
  • March 7, 2018
  • 165 views
Govt directs Fulfords India to maintain hepatitis injection production

New Delhi: Department of Pharmaceuticals said it has invoked powers under the Drugs Prices Control Order, 2013 to direct Fulfords India to maintain production, distribution and availability of Viraferonpeg 100…

  • Pharma
  • March 6, 2018
  • 177 views
Innovations in pharma packaging can check fake drugs : Yogesh Mudras

By Yogesh Mudras, MD, UBM India. The Indian pharma economy has witnessed rapid growth in recent decades and is known as one of the global pharma hubs, ranking fourth in…

  • Pharma
  • March 6, 2018
  • 166 views
Expert: Over 65% kids born with Vitamin D deficiency

NAGPUR: Over the last decade, more research on Vitamin D has brought to fore the severity of problems associated with its deficiency, said Pune-based Dr Pramod Jog, chairman of International…

  • Pharma
  • March 6, 2018
  • 162 views
Good news for Sun Pharma, bad news for Aurobindo: Amit Rajan, Prosfora Tech

Talking to ET Now, Amit Rajan, MD, Prosfora Tech, says Sun Pharma’s oral approvals technically will start from next month itself. Edited excerpts: What do you make of the observations…

  • Pharma
  • March 5, 2018
  • 173 views
The curious case of USFDA observations and skyrocketing stock prices

The question no one is asking: Why isn’t the Securities and Exchange Board of India (SEBI) ordering Indian pharmaceutical companies to disclose to Indian stock exchanges the details of the…

  • Pharma
  • March 3, 2018
  • 187 views
DSM launches sale of anti-infectives maker DSP – sources

By Ludwig Burger and Arno Schuetze FRANKFURT, – Dutch speciality chemicals company DSM has launched the sale of its anti-infectives unit DSM Sinochem Pharmaceuticals (DSP), a potential 640 million euro…

  • Pharma
  • March 3, 2018
  • 170 views
PMC’s cancer screening drive from March 3

Come March the Pune Municipal Corporation’s (PMC’s) health department will start screening women for oral, cervical and breast cancer. The civic body is expected to start the initiative on March…